Senolytics can alleviate multiple age-related diseases.
Dasatinib and quercetin were the first successful senolytic drugs.
Clinical trials for Alzheimer's disease using senolytics began recently.
First human trial of D + Q showed improved physical function in IPF patients.
Second generation senolytics aim for greater selectivity and fewer side effects.
Create your account to keep this answer and continue from it later.
Let's look at alternatives: